MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

April 2003


Letter to the Editor

Providers to Share Data About Causes of Medical Errors

The Patient Safety and Quality Improvement Act (H.R.663) encourages providers to conduct research and gather data about the causes of medical mishaps and then share their findings with other providers.
Cheryl Servais

Pharmaceutical-Approval Update

The author reviews adalimumab for rheumatoid arthritis, alefacept for psoriasis, and cyclosporine ophthalmic emulsion for chronic dry eye disease.
Marvin M. Goldenberg, PhD, RPh, MS

Physician Perspective

What’s Going to Happen to Brave Surgeons and Patients?

A practicing physician describes the fears that surgeons must confront when treating high-risk patients.
Thomas Marzili, MD

Continuing Education Credit

Voriconazole: A New Triazole Antifungal Agent

The author reviews a new medication for the treatment of invasive aspergillosis, febrile neutropenia, and candidiasis.
S. Scott Sutton, PharmD



Advocating Health for Greater Productivity and Improved Morale

Editor-in-Chief David Nash, MD, MBA, highlights a company that helps employees resolve problems with their health benefits.
David B. Nash, MD, MBA


Welcome, Dr. Greengold

Dr. Nancy Greengold is the newest addition to P&T’s Editorial Board.
Sonja Sherritze

Medication Errors

“Rule of 6” Not Optimal for Patient Safety

Matthew Grissinger discusses the “rule of 6” shortcut and its tendency to lead to errors.
Matthew Grissinger

Prescription Washington

The Medicare Mess and Congressional Chaos

Stephen Barlas describes the confusion surrounding President Bush’s proposed Medicare drug benefit.
Stephen Barlas

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA

Drug Forecast

Aripiprazole: A New Antipsychotic Agent with a Unique Mechanism of Action

Dr. Vanni and Mr. Inzerillo review aripiprazole, a new antipsychotic medication.
Nicholas Vanni, PharmD, and Michael T. Inzerillo, MBA

Use of Antifungal Therapies in Patients with Sepsis